ZENDAL

ZENDAL is an international biopharmaceutical group with a solid track record in the development and production of vaccines, pharmaceutical products, and probiotics for both human and animal health. With a presence in over 65 countries, we are committed to delivering effective and innovative health solutions through a strong scientific and technological vision aligned with global health challenges. In recent years, ZENDAL has strengthened its leadership through strategic investment in R&D, new biopharmaceutical infrastructures, and corporate growth. This commitment has translated into enhanced technical and production capabilities in biotechnology, significantly expanding our global reach. Driven by a strong spirit of innovation, ZENDAL continues to move forward with the goal of anticipating major global health challenges. We are committed to talent, innovation, and purpose as the key pillars to continue protecting health through high-impact biotechnological solutions.